Jiang et al. reported an increasing number of B2M mutations in refractory or relapse DLBCL using deep sequencing, revealing the novel clonal evolution and mutational patterns [29], while CD70 mutations were reported to be commonly associated with the B2N subtype in DLBCL [17]. The gene discussed is B2M; the disease is diffuse large B-cell lymphoma.